Literature DB >> 19005265

HIV clinical trial design for antiretroviral development: moving forward.

Kirk M Chan-Tack1, Kimberly A Struble, Nathalie Morgensztejn, Jeffrey S Murray, Roy Gulick, Ben Cheng, Ian Weller, Veronica Miller.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 19005265     DOI： 10.1097/QAD.0b013e32831692e6

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  3 in total

1.  Considerations for Endpoint Selection When Designing HIV Clinical Trials.

Authors:  Katherine Huppler Hullsiek; Birgit Grund
Journal:  Curr Infect Dis Rep       Date:  2012-02       Impact factor: 3.725

Review 2.  Novel clinical trial designs for the development of new antiretroviral agents.

Authors:  Nina Mani; Jeffrey Murray; Roy M Gulick; Filip Josephson; Veronica Miller; Peter Miele; Jur Strobos; Kimberly Struble
Journal:  AIDS       Date:  2012-05-15       Impact factor: 4.177

3.  The design of single-arm clinical trials of combination antiretroviral regimens for treatment-naive HIV-infected patients.

Authors:  Lu Zheng; Susan L Rosenkranz; Babafemi Taiwo; Michael F Para; Joseph J Eron; Michael D Hughes
Journal:  AIDS Res Hum Retroviruses       Date:  2013-01-09       Impact factor: 2.205
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.